EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Decision-Oriented Calibrated Screening Workflow for Tylosin Derivatives: Closed-Loop MIC Validation Against Staphylococcus aureus and Streptococcus agalactiae

Huan Liu, Yiming Liu iD, Na Yu iD, Miao An, Yaoxin Tang, Jing Qu, Xiubo Li

Antibiotics · 08.07.2026 · 15 (7) · 666

DOI: 10.3390/antibiotics15070666 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antibiotics, online erschienen am 08.07.2026. Verfasst von Huan Liu und 6 weiteren Autor:innen. Beteiligte Einrichtung: National Feed Drug Reference Laboratories, Feed Research Institute, Chinese Academy of Agricultural Sciences, Beijing 100081, China. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key R&D Program, Agricultural Science and Technology Innovation Program, National Key R&D Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Antimicrobial resistance among Gram-positive veterinary pathogens has increased the need for more rational and experimentally grounded strategies to prioritize tylosin derivatives for antibacterial development. This study aimed to develop and externally a calibrated, decision-oriented screening workflow for tylosin-derived antibacterial analog prioritization against Staphylococcus aureus and Streptococcus agalactiae.

Methods

Publicly available minimum inhibitory concentration (MIC) data were used to construct organism-specific multilayer perceptron models. Model performance was evaluated using a five-fold out-of-fold framework. Calibrated activity probabilities were then combined with precision-oriented thresholds and similarity-based applicability-domain constraints to define prospective Go/No-Go decisions. To examine external transferability, six synthesized tylosin derivatives (A1–A6) were prospectively predicted and subsequently tested using in vitro MIC assays.

Results

Internal validation showed stronger and more stable performance for S. aureus than for S. agalactiae. However, closed-loop external validation revealed distinct organism-specific decision behaviors. For S. aureus, the workflow assigned Go decisions to five compounds and included the only experimentally active analog, A6, but also generated several false Go decisions for inactive analogs. For S. agalactiae, all six compounds were classified as No-Go under the primary decision rule, whereas MIC testing showed that four analogs were experimentally active, indicating conservative under-selection in a low-data extrapolation setting.

Conclusions

Calibrated probabilities and applicability-domain analysis can improve the transparency and diagnostic value of antibacterial prioritization, but they do not guarantee robust external activity prediction when training-set coverage, threshold transferability, or chemical-space representation is limited. Overall, this study provides an early-stage, risk-aware closed-loop decision-support framework for tylosin-derived analog prioritization and highlights the need for iterative model updating, probability recalibration, and larger external validation before such workflows are used as high-confidence prospective screening tools in veterinary antibacterial discovery.

Schlagwörter

Stichwörter der Autor:innen

Staphylococcus aureusStreptococcus agalactiaeantimicrobial screeningapplicability domaincalibrated probabilitytylosin derivatives

Autor:innen und Institutionen

  • National Feed Drug Reference Laboratories, Feed Research Institute, Chinese Academy of Agricultural Sciences, Beijing 100081, China.
  • Key Laboratory of Animal Antimicrobial Resistance Surveillance, Ministry of Agriculture and Rural Affairs, Feed Research Institute, Chinese Academy of Agricultural Sciences, Beijing 100081, China.
  • Laboratory of Quality and Safety Risk Assessment for Products on Feed-Origin Risk Factor, Ministry of Agriculture and Rural Affairs, Feed Research Institute, Chinese Academy of Agricultural Sciences, Beijing 100081, Chi…

ORCID-Profile: Yiming Liu, Na Yu

Förderung

  • National Key R&D Program
  • Agricultural Science and Technology Innovation Program
  • National Key R&D Program of China

Zitieren

APA

Liu, H., Liu, Y., Yu, N., An, M., Tang, Y., Qu, J., & Li, X. (2026). A Decision-Oriented Calibrated Screening Workflow for Tylosin Derivatives: Closed-Loop MIC Validation Against Staphylococcus aureus and Streptococcus agalactiae. Antibiotics, 15(7), 666. https://doi.org/10.3390/antibiotics15070666

Vancouver

Liu H, Liu Y, Yu N, An M, Tang Y, Qu J, et al. A Decision-Oriented Calibrated Screening Workflow for Tylosin Derivatives: Closed-Loop MIC Validation Against Staphylococcus aureus and Streptococcus agalactiae. Antibiotics. 2026;15(7):666. doi:10.3390/antibiotics15070666

BibTeX
@article{Liu2026,
  author = {Liu, Huan and Liu, Yiming and Yu, Na and An, Miao and Tang, Yaoxin and Qu, Jing and Li, Xiubo},
  title = {A Decision-Oriented Calibrated Screening Workflow for Tylosin Derivatives: Closed-Loop MIC Validation Against Staphylococcus aureus and Streptococcus agalactiae},
  journal = {Antibiotics},
  year = {2026},
  volume = {15},
  number = {7},
  pages = {666},
  doi = {10.3390/antibiotics15070666}
}
Kostenlos starten →